Skip to content

Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty

Efficacy of Experienced Chinese Herbal Formulas for the Treatment of Different Types of Precocious Puberty: A Single-blinded Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02650141
Enrollment
143
Registered
2016-01-08
Start date
2013-04-30
Completion date
2016-04-30
Last updated
2019-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Precocious Puberty

Brief summary

Due to various complex factors, the incidence of precocious puberty is increasing rapidly. It severely threatens physical and mental health of children. It's urgent to explore effective ways to control the disease.

Detailed description

In the research, 138 precocious puberty children are randomly divided into the Ziyinxiehuo granules group (69 cases) and Zishenqinggan granules group(69 cases). Patients in Ziyinxiehuo granules group are treated with a series of experienced chinese herbal formulas, whereas the Zishenqinggan granules group received with different series of experienced chinese herbal formulas.

Interventions

DRUGziyinxiehuo Granules

Ziyinxiehuo granules Herbs (1 bag ): shengdi 5g, xuanshen 3g, zexie 3g, zhimu3g, huangpai 3g, zhiguiban 2g, maiya 6g,tiandong 3g, zhigancao 2g Therapeutic Principle: Nourishing Yin, removing Fire Usage: administered after dissolved, 3 times per day after breakfast and supper

DRUGzishenqinggan Granules

Zishenqinggan granules Herbs (1 bag ): Shengdi 5g, baishao 3g, huangqin 3g, fuling 4g, danpi 3g, maiya 6g, shanzha 3g, zhebei 3g, zhigancao 2g Therapeutic Principle: replenishing Kidney, Clearing Liver Usage: administered after dissolved, 3 times per day after breakfast and supper

Sponsors

Children's Hospital of Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
No minimum to 8 Years
Healthy volunteers
No

Inclusion criteria

1. In the partial precocious puberty children: Inclusion Criteria: * Girls are diagnosed as simple early breast development, and their age of onset is less than 8 years * Tanner stages of breast in female patients are Tanner II and Tanner III, Diameter of mammary nucleus is less than 3cm; * B-type ultrasonography: the size and volume of uterus and follicle is in the normal range at the same age; * bone age: the bone age in the patients are the same with their actual age.

Exclusion criteria

* the bone age is advanced by more than 1 standard deviations for chronological age * pseudo sexual precocity, including gonadal tumor,adrenal disease,exogenous intake induced with hormone drugs or food and multiple bone fiber structure dysplasia of precocious puberty (McCune Albright syndrome) * heterosexual precocious puberty 2. In the mild true precocious puberty children: Inclusion Criteria: * Girls are diagnosed as Idiopathic central precocious puberty,and their age of onset ≤8 years * Tanner stages of brest in female patients ≤ Tanner III stage,diameter of mammillary nucleus \< 3cm * B-type ultrasonography: the volume of uterus≥1\ 3ml,the diameter of follicle≥4mm;or the length of uterus ≥3.4-4cm * bone age: compared the actual age ,the bone age is no more than 1 year and the bone age \<10 years old; * in master single test: LH \>3 IU/L * GnRH stimulation test: LH/FSH\>0.6, the Peak LH 3.5\ 5.0 IU/L, the Peak LH 3.5\ 5.0 IU/L.

Design outcomes

Primary

MeasureTime frameDescription
Change in some index of B type ultrasonography ( uterus,ovary,follicle )3 months, 6monthsThe investigators will measure the change of some index of B type ultrasonography ( the volume of uterus and ovary, the biggest follicle diameter )

Secondary

MeasureTime frameDescription
change in the mammary nucleus index3 months, 6 monthsThe investigators will measure the change of the mammary nucleus index by the mammary diameter
change in the cumulative score of traditional Chinese medicine syndromes3 months, 6 monthsThe investigators will measure the change in scores of chinese medicine symptoms according to the Traditional Chinese Medicine Guideline Scale: 0 - 3. 0 = None. 1 = Mild. 2 = Moderate. 3= Severe

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026